Back

Association between intensity of glycemic control with GLP-1 receptor agonists and risk of atherosclerotic cardiovascular disease: a systematic review and meta-regression

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (4) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Daniel Gomes

Hospital Santa Cruz, Lisbon (Portugal)

3 More presentations in this session

Presentation thumbnail
Association of dietary salt intake with diabetes mellitus in the Japanese general population
Doctor S. Nakano (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled type 2 diabetes mellitus: a comparison of cardiovascular effects
Doctor S. Tremamunno (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Long-term spermidine therapy potentially protects the heart against estrogen deprivation in female rats via suppressing cardiac mitochondrial dysfunction, inflammation, oxidative stress, and apoptosis
Miss W. KAOROP (Chiang Mai, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (4)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
thumbnail
Congress Presentation
GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis
thumbnail
Congress Presentation
A real-world data analysis investigating the cardioprotective effects of glucagon-like peptide-1 receptor agonists among people with type 2 diabetes in England

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources